CIK 0002022416
- Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +972 86286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Shirvan Mitchell CSO and CDO | Grant or award | +6,000 | 8,789 | ||
| 2026-03-26 | Shirvan Mitchell CSO and CDO | Sale | −22,818 | $1.36 | $31K | 27,889 |
| 2026-02-20 | Shirvan Mitchell CSO and CDO | Grant or award | +49,726 | 50,707 |
Page 1 of 1 · 3 trades